Lupanine improves glucose homeostasis by influencing KATP channels and insulin gene expression

Molecules

Volumn 20, Issue 10, 2015, Pages 19085-19100

  Wiedemann, Mats ^a   Gurrola Díaz, Carmen M ^b   Vargas Guerrero, Belinda ^b   Wink, Michael ^c   García López, Pedro M ^b   Düfer, Martina ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Beta cell; Glucose tolerance; Insulin secretion; KATP channel; Lupanine; Lupinus; Membrane potential; Quinolizidine alkaloids; Streptozotocin; Type 2 diabetes mellitus

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ARGININE; GLUCOSE BLOOD LEVEL; INSULIN; LUPANINE; SPARTEINE; STREPTOZOCIN;

ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; RAT; SECRETION (PROCESS);

ANIMALS; ARGININE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENE EXPRESSION REGULATION; HOMEOSTASIS; INSULIN; INSULIN-SECRETING CELLS; KATP CHANNELS; MICE; MICE, INBRED C57BL; RATS; SPARTEINE; STREPTOZOCIN;

EID: 84947557999     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201019085     Document Type: Article

References (29)

1. Mansour, H.A.; Newairy, A.-S.A.; Yousef, M.; Sheweita, S. Biochemical study on the effects of some egyptian herbs in alloxan-induced diabetic rats. Toxicology 2002, 170, 221-228.
2. Baldeón, M.; Castro, J.; Villacrés, E.; Narváez, L.; Fornasini, M. Hypoglycemic effect of cooked lupinus mutabilis and its purified alkaloids in subjects with type-2 diabetes. Nutr. Hosp. 2012, 27, 1261-1266.
3. Fornasini, M.; Castro, J.; Villacrés, E.; Narváez, L.; Villamar, M.P.; Baldeón, M. Hypoglycemic effect of lupinus mutabilis in healthy volunteers and subjects with dysglycemia. Nutr. Hosp. 2012, 27, 425-433.
4. Bobkiewicz-Kozøowska, T.; Dworacka, M.; Kuczyński, S.; Abramczyk, M.; Kolanos̈, R.; Wysocka, W.; García-Lopez, P.M.; Winiarska, H. Hypoglycaemic effect of quinolizidine alkaloids - Lupanine and 2-thionosparteine on non-diabetic and streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2007, 565, 240-244.
5. Lovati, M.R.; Manzoni, C.; Castiglioni, S.; Parolari, A.; Magni, C.; Duranti, M. Lupin seed γ-conglutin lowers blood glucose in hyperglycaemic rats and increases glucose consumption of HEPG2 cells. Br. J. Nutr. 2012, 107, 67-73.
6. Schmeller, T.; Sauerwein, M.; Sporer, F.; Wink, M.; Müller, W.E. Binding of quinolizidine alkaloids to nicotinic and muscarinic acetylcholine receptors. J. Nat. Prod. 1994, 57, 1316-1319.
7. Körper, S.; Wink, M.; Fink, R.H. Differential effects of alkaloids on sodium currents of isolated single skeletal muscle fibers. FEBS Lett. 1998, 436, 251-255.
8. Wink, M. Interference of alkaloids with neuroreceptors and ion channels. Stud. Nat. Prod. Chem. 2000, 21, 3-122.
9. Paolisso, G.; Sgambato, S.; Passariello, N.; Pizza, G.; Torella, R.; Tesauro, P.; Varricchio, M.; d'Onofrio, F. Plasma glucose lowering effect of sparteine sulphate infusion in non-insulin dependent (type 2) diabetic subjects. Eur. J. Clin. Pharmacol. 1988, 34, 227-232.
10. Paolisso, G.; Nenquin, M.; Schmeer, W.; Mathot, F.; Meissner, H.; Henquin, J.C. Sparteine increases insulin release by decreasing the K+ permeability of the b-cell membrane. Biochem. Pharmacol. 1985, 34, 2355-2361.
11. García-López, P.M.; Garzón de la Mora, P.; Wysocka, W.; Maiztegui, B.; Alzugaray, M.E.; del Zotto, H.; Borelli, M.I. Quinolizidine alkaloids isolated from lupinus species enhance insulin secretion. Eur. J. Pharmacol. 2004, 504, 139-142.
12. Drews, G.; Krippeit-Drews, P.; Düfer, M. Electrophysiology of islet cells. In The Islets of Langerhans; Springer: Berlin, Germany, 2010; pp. 115-163.
13. Li, Y.; Hu, Y.; Ley, S.H.; Rajpathak, S.; Hu, F.B. Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: Prospective cohort study among women. Diabetes Care 2014, 37, 3106-3113.
14. Yanai, H.; Adachi, H.; Katsuyama, H.; Moriyama, S.; Hamasaki, H.; Sako, A. Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetes. World J. Diabetes 2015, 6, 30-36.
15. Ashcroft, F.M.; Kerr, A.J.; Gibson, J.S.; Williams, B.A. Amantadine and sparteine inhibit ATP-regulated K-currents in the insulin-secreting β-cell line, HIT-T15. Br. J. Pharmacol. 1991, 104, 579-584.
16. Plant, T. Properties and calcium-dependent inactivation of calcium currents in cultured mouse pancreatic b-cells. J. Physiol. 1988, 404, 731-747.
17. Pugsley, M.K.; Saint, D.A.; Hayes, E.; Berlin, K.D.; Walker, M.J. The cardiac electrophysiological effects of sparteine and its analogue BRB-I-28 in the rat. Eur. J. Pharmacol. 1995, 294, 319-327.
18. Pothier, J.; Cheav, S.L.; Galand, N.; Dormeau, C.; Viel, C. A comparative study of the effects of sparteine, lupanine and lupin extract on the central nervous system of the mouse. J. Pharm. Pharmacol. 1998, 50, 949-954.
19. Australia New Zealand Food Authority. Lupin Alkaloids in Food: A Toxicological Review and Risk Assessment; Australia New Zealand Food Authority: Canberra, Australia; Wellington, New Zealand, 2011.
20. Pingault, N.M.; Gibbs, R.A.; Barclay, A.M.; Monaghan, M. Two cases of anticholinergic syndrome associated with consumption of bitter lupin flour. Med. J. Aust. 2009, 191, 173-174.
21. Ruíz, M.A.; Sotelo, A. Chemical composition, nutritive value, and toxicology evaluation of mexican wild lupins. J. Agric. Food Chem. 2001, 49, 5336-5339.
22. Robbins, M.; Petterson, D.; Brantom, P. A 90-day feeding study of the alkaloids of lupinus angustifolius in the rat. Food Chem. Toxicol. 1996, 34, 679-686.
23. Wink, M.; Meißner, C.; Witte, L. Patterns of quinolizidine alkaloids in 56 species of the genus lupinus. Phytochemistry 1995, 38, 139-153.
24. Resta, D.; Boschin, G.; D'Agostina, A.; Arnoldi, A. Evaluation of total quinolizidine alkaloids content in lupin flours, lupin-based ingredients, and foods. Mol. Nutr. Food Res. 2008, 52, 490-495.
25. Terruzzi, I.; Senesi, P.; Magni, C.; Montesano, A.; Scarafoni, A.; Luzi, L.; Duranti, M. Insulin-mimetic action of conglutin-γ, a lupin seed protein, in mouse myoblasts. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 197-205.
26. Vargas-Guerrero, B.; García-López, P.M.; Martínez-Ayala, A.L.; Domínguez-Rosales, J.A.; Gurrola-Díaz, C.M. Administration of lupinus albus gamma conglutin (Cγ) to n5 STZ rats augmented Ins-1 gene expression and pancreatic insulin content. Plant. Foods Hum. Nutr. 2014, 69, 241-247.
27. Düfer, M. Determination of beta-cell function: Ion channel function in beta cells. In Animal Models in Diabetes Research; Springer: Berlin, Germany, 2012; pp 203-217.
28. Wink, M. Quinolizidine alkaloids. In Methods in Plant Biochemistry; Academic Press: London, UK, 1993; pp. 197-239.
29. Oeh, R.; Rieblinger, K.; Wink, M. Process for Extracting Alkaloids, in Particular Lupanin, from Alkaloid-Containing Plants. WO 19995032968 or DE 4418618 C1, 24 August 1995.